Teva Pharmaceutical Industries LtdTEVA:TLV

17,450
450.00 / 2.51%
600.60k
27.37%
0.5953
Close in ILAToday's changeShares traded1 year changeBeta
As of Apr 24 2014 15:24 BST.Data delayed by at least 20 minutes.

Summary

On Thursday, Teva Pharmaceutical Industries Ltd (TEVA:TLV) closed at 17,450, 6.83% below its 52-week high of 18,730, set on Apr 02, 2014.

52-week range
Today
12,800
Nov 05 2013
18,730
Apr 02 2014
Markit short selling activity
Low
Medium
High
Open17,650
Day high17,730
Day low17,380
Bid17,450
Offer17,490
Previous close17,900
Average volume424.11k
Shares outstanding949.73m
Free float935.31m
P/E (TTM)34.48
Market cap170.10bn ILS
EPS (TTM)5.19 ILS
Annual div (TTM)396.10 ILS
Annual div yield (TTM)2.21%
Div ex-dateFeb 24 2014
Div pay-dateMar 10 2014

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Teva Pharmaceutical Industries Ltd+0.69%+2.95%+22.97%+27.37%-5.73%
TASE TA-100 IDX+0.18%-0.73%+8.50%+16.36%+76.55%
IL/HEALTH CARE+3.18%+5.31%+20.73%+23.46%--
IL/PHARMACEUTICALS+3.18%+5.31%+20.73%+23.46%--
As of Apr 24 2014 15:24 BST.Data delayed by at least 20 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.